UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000010844
Receipt number	R000012460
Scientific Title	Phase II trial with eribulin and trastuzumab for advanced/recurrent HER2-positive breast cancer
Date of disclosure of the study information	2013/06/15
Last modified on	2013/05/30 17:19:51

---